Joe DeSimone | |
---|---|
DeSimone in 2010
|
|
Born | May 16, 1964 |
Citizenship | United States |
Nationality | United States |
Institutions | University of North Carolina at Chapel Hill, North Carolina State University |
Alma mater | Ursinus College, Virginia Polytechnic Institute and State University |
Thesis | Synthesis of well-defined single and multiphase polymers using various living polymerization methods (1990) |
Doctoral advisor | James E. McGrath |
Notable students | Andrew Ian Cooper (postdoc) |
Notable awards |
National Medal of Technology and Innovation (2013) Lemelson–MIT Prize (2008) IRI Medal (2014) |
Joseph DeSimone: What if 3D printing was 100x faster?, TED Talks |
Joseph M. DeSimone (born May 16, 1964) is an American chemist, inventor and entrepreneur, best known as the 2008 recipient of the $500,000 Lemelson–MIT Prize and as the co-founder and CEO of Carbon, an American technology company.
He is the Chancellor's Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill, and William R. Kenan, Jr. Distinguished Professor of Chemical Engineering at North Carolina State University and of Chemistry at UNC. DeSimone is also an adjunct member at Memorial Sloan-Kettering Cancer Center.
DeSimone has published over 300 scientific articles and has over 150 issued patents in his name with over 80 patents pending.
Joseph DeSimone received his BS in Chemistry in 1986 from Ursinus College in Collegeville, Pennsylvania and his Ph.D. in Chemistry in 1990 from Virginia Tech in Blacksburg, Virginia.
DeSimone is a member of the National Academy of Medicine (2014),National Academy of Sciences (2012), and the National Academy of Engineering (2005), and is a member of the American Academy of Arts and Sciences (2005).
He had developed an environmentally friendly manufacturing process that relies on supercritical carbon dioxide instead of water and bio-persistent surfactants for the creation of fluoropolymers or high-performance plastics, such as Teflon. In 2002, DeSimone, along with Dr. Richard Stack, a cardiologist at Duke University, co-founded Bioabsorbable Vascular Solutions (BVS) to commercialize a fully bioabsorbable, drug-eluting stent. BVS was acquired by Guidant in 2003, being evaluated in a series of international clinical trials for the treatment of coronary artery disease.